Sign in

CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943134940
Phone
4154825300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$43,476
in 2 filings

Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBIN HOWARD W −$30K President & CEO sold <1% of stake
  2. Zalevsky Jonathan −$13K Chief R&D Officer sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-09-25 Ajer Jeffrey Robert Director Grant or award +6,500 24,750
2019-09-25 Ajer Jeffrey Robert Director Grant or award · Stock Option +13,000 13,000
2019-09-20 Ajer Jeffrey Robert Director Sale −2,250 $20.24 $46K 18,250
2019-09-16 Labrucherie Gil M SVP & Chief Financial Officer Option exercise +25,000 $7.21 $180K 177,872
2019-09-16 Labrucherie Gil M SVP & Chief Financial Officer Sale −25,000 $20.52 $513K 152,872
2019-09-16 Labrucherie Gil M SVP & Chief Financial Officer Option exercise · Stock Option −25,000 50,000
2019-09-05 Doberstein Stephen K SVP & Chief Scientific Officer Purchase +15,000 $17.28 $259K 107,668
2019-08-26 Labrucherie Gil M SVP & Chief Financial Officer Option exercise +30,000 $16.31 $489K 152,872
2019-08-26 Labrucherie Gil M SVP & Chief Financial Officer Option exercise · Stock Option −30,000 57,500
2019-08-23 ROBIN HOWARD W President & CEO Option exercise +30,000 $16.31 $489K 312,775
2019-08-23 ROBIN HOWARD W President & CEO Option exercise · Common Stock −30,000 195,000
2019-08-16 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −1,809 $18.15 $33K 163,154
2019-08-16 ROBIN HOWARD W President & CEO Sale −12,551 $18.15 $228K 282,775
2019-08-16 Nicholson John SVP & Chief Operating Officer Sale −3,819 $18.15 $69K 162,759
2019-08-16 Labrucherie Gil M SVP & Chief Financial Officer Sale −5,063 $18.15 $92K 122,872
2019-08-16 Doberstein Stephen K SVP & Chief Scientific Officer Sale −3,245 $18.15 $59K 92,668
2019-08-14 Labrucherie Gil M SVP & Chief Financial Officer Option exercise +25,000 $7.21 $180K 152,935
2019-08-14 Labrucherie Gil M SVP & Chief Financial Officer Sale −25,000 $17.79 $445K 127,935
2019-08-14 Labrucherie Gil M SVP & Chief Financial Officer Option exercise · Stock Option −25,000 0
2019-07-25 ROBIN HOWARD W President & CEO Option exercise +33,333 $7.21 $240K 328,659

Page 24 of 29 · 562 trades